Blonanserin suppresses impulsive action in rats.
1-PP
Antipsychotics
Impulsive behavior
Journal
Journal of pharmacological sciences
ISSN: 1347-8648
Titre abrégé: J Pharmacol Sci
Pays: Japan
ID NLM: 101167001
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
received:
05
04
2019
revised:
12
08
2019
accepted:
11
09
2019
pubmed:
7
11
2019
medline:
28
3
2020
entrez:
7
11
2019
Statut:
ppublish
Résumé
High impulsivity will increase the risk of criminal behavior, drug abuse, and suicide. We chose two drugs by following a strategy recently we proposed for identifying potential anti-impulsivity drugs, and examined the effects on impulsive action in rats by using a 3-choice serial reaction time task. We showed that the administration of blonanserin, an atypical antipsychotic, reduced impulsive actions in a U-shaped manner. 1-(2-Pyriidinyl)-piperazine, an active metabolite of buspirone or tandospirone, also slightly reduced impulsive actions, though it impaired motor functions. These results affirm the validity of our strategy, but require its refinement for developing anti-impulsivity drugs.
Identifiants
pubmed: 31690490
pii: S1347-8613(19)35718-4
doi: 10.1016/j.jphs.2019.09.013
pii:
doi:
Substances chimiques
Antipsychotic Agents
0
Piperazines
0
Piperidines
0
blonanserin
AQ316B4F8C
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
127-130Informations de copyright
Copyright © 2019 The Authors. Production and hosting by Elsevier B.V. All rights reserved.